カテゴリ： MarketLine, スイス, 企業調査

F. Hoffmann-La Roche Ltd：企業のM&A・事業提携・投資動向

◆英語タイトル：F. Hoffmann-La Roche Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード：DATA904C2065
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：178
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD700 ⇒換算￥103,600見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD1,050 ⇒換算￥155,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

F. Hoffmann-La Roche Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s F. Hoffmann-La Roche Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by F. Hoffmann-La Roche Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes F. Hoffmann-La Roche Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by F. Hoffmann-La Roche Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on F. Hoffmann-La Roche Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by F. Hoffmann-La Roche Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for F. Hoffmann-La Roche Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about F. Hoffmann-La Roche Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 10
Corporate Venturing – Overview 10
Corporate Venturing – Deal reports 11
PARTNERSHIP 18
Partnership – Overview 18
Partnership – Deal reports 19
Divestments – Deal reports 164
APPENDIX 168
Contact Us 168
About MarketLine Financial Deals Database 168
Deal Definition and Methodology 170
About MarketLine 177

List of Tables
Table 1: F. Hoffmann-La Roche Ltd M&A volume and value trend (2014-YTD2018)
Table 2: F. Hoffmann-La Roche Ltd M&A activity by geography (2014-YTD2018)
Table 3: F. Hoffmann-La Roche Ltd corporate venturing volume and value trend (2014-YTD2018)
Table 4: F. Hoffmann-La Roche Ltd corporate venturing by geography (2014-YTD2018)
Table 5: F. Hoffmann-La Roche Ltd partnership volume and value trend (2014-YTD2018)
Table 6: F. Hoffmann-La Roche Ltd partnership trend by key deal type (2014-YTD2018)

List of Figures
Figure 1: F. Hoffmann-La Roche Ltd M&A volume and value trend (2014-YTD2018)
Figure 2: F. Hoffmann-La Roche Ltd M&A activity by geography (2014-YTD2018)
Figure 3: F. Hoffmann-La Roche Ltd corporate venturing volume and value trend (2014-YTD2018)
Figure 4: F. Hoffmann-La Roche Ltd corporate venturing by geography (2014-YTD2018)
Figure 5: F. Hoffmann-La Roche Ltd partnership volume and value trend (2014-YTD2018)
Figure 6: F. Hoffmann-La Roche Ltd partnership trend by key deal type (2014-YTD2018)

★海外企業調査レポート[F. Hoffmann-La Roche Ltd：企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Didion Milling Inc.：企業の戦略・SWOT・財務情報
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Event Hospitality & Entertainment Limited：戦略・SWOT・企業財務分析
    Event Hospitality & Entertainment Limited - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • UCO Bank：戦略・SWOT・企業財務分析
    UCO Bank - Strategy, SWOT and Corporate Finance Report Summary UCO Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Exiqon AS：製薬・医療：M&Aディール及び事業提携情報
    Summary Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reag …
  • FRONTEO, Inc. (2158)：企業の財務・戦略的SWOT分析
    FRONTEO, Inc. (2158) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biosense Webster Inc：企業の製品パイプライン分析2018
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Supreme Group B.V.：企業の戦略・SWOT・財務分析
    Supreme Group B.V. - Strategy, SWOT and Corporate Finance Report Summary Supreme Group B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Yuma Energy Inc (YUMA)：石油・ガス：M&Aディール及び事業提携情報
    Summary Yuma Energy Inc (Yuma) is an exploration and production company that offers acquisition, development, and exploration for conventional and unconventional oil and natural gas resources in the Gulf Coast and the Permian Basin of west Texas and California. The company designs and performs its o …
  • Intersect ENT Inc (XENT)：企業の財務・戦略的SWOT分析
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc, is a medical technology company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Inte …
  • CHC Group LLC：企業の戦略的SWOT分析
    CHC Group LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • IQVIA Holdings Inc (IQV)：医療機器：M&Aディール及び事業提携情報
    Summary IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commerc …
  • Bionure Farma SL-製薬・医療分野：企業M&A・提携分析
    Summary Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment which include optic neuritis and neuromyelitis optica. Its …
  • Taiwan Liposome Company Ltd (4152)：製薬・医療：M&Aディール及び事業提携情報
    Summary Taiwan Liposome Company Ltd (TLC) is a clinical-stage pharmaceutical company that develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of ad …
  • NBN Co Ltd：企業の戦略的SWOT分析
    NBN Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Berthold Technologies GmbH & Co. KG：企業の戦略的SWOT分析
    Berthold Technologies GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SEAS-NVE Holding AS：企業の戦略的SWOT分析
    SEAS-NVE Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • YGM Trading Ltd.：企業の戦略・SWOT・財務情報
    YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • FIT Biotech Oy (FITBIO)：企業の財務・戦略的SWOT分析
    Summary FIT Biotech Oy (FIT Biotech), formerly Finnish Immunotechnology Oy is a biotechnology company that develops and commercializes gene-based treatments for cancer and a range of infectious diseases. Its patented gene transfer technology is used for the development of drug candidates which inclu …
  • ShotSpotter Inc (SSTI)：企業の財務・戦略的SWOT分析
    ShotSpotter Inc (SSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • American Woodmark Corp (AMWD)：企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆